<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04803214</url>
  </required_header>
  <id_info>
    <org_study_id>980012</org_study_id>
    <nct_id>NCT04803214</nct_id>
  </id_info>
  <brief_title>ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation</brief_title>
  <acronym>RESTORE</acronym>
  <official_title>ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mainstay Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mainstay Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical&#xD;
      Management (OMM).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2021</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Oswestry Disability Index (ODI)</measure>
    <time_frame>1 year</time_frame>
    <description>Comparison of 1-year change from baseline in ODI between Treatment and Control. ODI is measured on a scale of 0 to 100 where a higher score is a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Low Back Pain Numerical Rating Scale (LBP NRS)</measure>
    <time_frame>1 year</time_frame>
    <description>Comparison of 1-year change from baseline in LBP NRS between Treatment and Control.&#xD;
NRS is measured on a scale of 0 to 10 where a higher score is a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-5D</measure>
    <time_frame>1 year</time_frame>
    <description>Comparison of 1-year change from baseline in EQ-5D between Treatment and Control.&#xD;
EQ-5D is measured on a scale of -0.5 to 1.0 where a higher score is a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Chronic Low-back Pain</condition>
  <arm_group>
    <arm_group_label>Treatment (ReActiv8)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Market-approved ReActiv8 device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (OMM)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReActiv8</intervention_name>
    <description>Market-approved ReActiv8 device implanted</description>
    <arm_group_label>Treatment (ReActiv8)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥21 years&#xD;
&#xD;
          2. Evidence of lumbar multifidus muscle dysfunction&#xD;
&#xD;
          3. Intractable Chronic Low Back Pain that has persisted &gt;6 months resulting in pain most&#xD;
             of the days in the past 12 months&#xD;
&#xD;
          4. Failed therapy including pain medications and physical therapy&#xD;
&#xD;
          5. Not a candidate for spine surgery&#xD;
&#xD;
          6. Low Back Pain NRS of ≥6 and ≤9&#xD;
&#xD;
          7. Oswestry Disability Index score ≥30 and ≤60&#xD;
&#xD;
          8. Willing and capable of giving Informed Consent&#xD;
&#xD;
          9. Able to comply with this protocol&#xD;
&#xD;
         10. On Optimal Medical Management per the Investigator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindicated for the ReActiv8 System&#xD;
&#xD;
          2. BMI &gt; 35&#xD;
&#xD;
          3. Any surgical correction procedure for scoliosis at any time, or a current clinical&#xD;
             diagnosis of moderate to severe scoliosis&#xD;
&#xD;
          4. An independent MRI assessment identifying a pathology that is likely the cause of the&#xD;
             CLBP and is amenable to surgery&#xD;
&#xD;
          5. Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain)&#xD;
             below the knee&#xD;
&#xD;
          6. Any condition unrelated to CLBP which, in the opinion of the Investigator, could limit&#xD;
             physical movement or compliance with the protocol, or interfere with the assessment of&#xD;
             efficacy&#xD;
&#xD;
          7. Surgical and other procedure exclusions&#xD;
&#xD;
          8. Psycho-social exclusions&#xD;
&#xD;
          9. Protocol compliance exclusions&#xD;
&#xD;
         10. General exclusions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Schwab</last_name>
    <role>Study Chair</role>
    <affiliation>New York-Presbyterian</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Burnside</last_name>
    <phone>763-270-5303</phone>
    <email>diane.burnside@mainstay-medical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Smith Dodson</last_name>
      <phone>501-526-7906</phone>
      <email>dodsonsusansmith@uams.edu</email>
    </contact>
    <investigator>
      <last_name>Johnathan Goree</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Spine, Pain and Performance Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelynne Morris</last_name>
      <phone>202-808-8295</phone>
      <email>emorris@isppcenter.com</email>
    </contact>
    <investigator>
      <last_name>Mehul Desai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augusta Orthopedic &amp; Sports Medicine Specialists</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Martin</last_name>
      <phone>706-863-9797</phone>
      <phone_ext>214</phone_ext>
      <email>tinam@ortho-augusta.com</email>
    </contact>
    <investigator>
      <last_name>Justin Bundy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana Spine Group</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheetal Vinayek</last_name>
      <phone>317-715-5897</phone>
      <email>svinayek@indianaspinegroup.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Gentile</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OrthoIndy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46278</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Glover</last_name>
      <phone>317-802-2880</phone>
      <email>mglover@orthoindy.com</email>
    </contact>
    <investigator>
      <last_name>Meredith Langhorst</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Clinical Research, LLC</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Boles</last_name>
      <phone>336-765-6181</phone>
      <phone_ext>136</phone_ext>
      <email>lboles@ccrpain.com</email>
    </contact>
    <investigator>
      <last_name>Christopher Gilmore</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Yassa</last_name>
      <phone>216-445-5132</phone>
      <email>Yassap@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Shrif Costandi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spinal Diagnostics, PC</name>
      <address>
        <city>Tualatin</city>
        <state>Oregon</state>
        <zip>97062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Strickler</last_name>
      <phone>503-885-1515</phone>
      <email>evelyns@spinaldx.com</email>
    </contact>
    <investigator>
      <last_name>Robert Heros</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Interventional Pain and Spine</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Scherer</last_name>
      <phone>844-365-7246</phone>
      <email>ashleys@centerisp.com</email>
    </contact>
    <investigator>
      <last_name>Michael Fishman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 14, 2021</study_first_submitted>
  <study_first_submitted_qc>March 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurostimulation</keyword>
  <keyword>Stimulation</keyword>
  <keyword>Multifidus</keyword>
  <keyword>Restorative neurostimulation</keyword>
  <keyword>Multifidus muscle control</keyword>
  <keyword>Neurostimulator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

